EPOS™
Mechanism of action of imatinib | Biomed Graphics
Journal of Biomedical and Pharmaceutical Research
What is Gleevec? - Quora
Imatinib - Wikipedia
Frontiers | Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation
Imatinib Mesylate — A New Oral Targeted Therapy | NEJM
Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events | Arteriosclerosis, Thrombosis, and Vascular Biology
Defining molecular mechanisms of imatinib treatment in GIST - The Life Raft Group
Modern Therapy of Chronic Myeloid Leukemia | IntechOpen
Defining molecular mechanisms of imatinib treatment in GIST - The Life Raft Group
FDA licences imatinib mesylate for CML - The Lancet Oncology
Journal of Biomedical and Pharmaceutical Research
Immunological off-target effects of imatinib | Nature Reviews Clinical Oncology
Imatinib - an overview | ScienceDirect Topics
Imatinib Pathway, Pharmacokinetics/Pharmacodynamics
5MJCB4-TKI
File:Mechanism imatinib.svg - Wikimedia Commons
Immunomodulatory effects of imatinib and second-generation tyrosine kinase inhibitors on T cells and dendritic cells: an update - Cytotherapy
Nilotinib Pathway, Pharmacokinetics/Pharmacodynamics
Imatinib mechanism of action
Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy | Journal of Hematology & Oncology | Full Text
